BioSpace News Archive

Amydis Inc. announced initiation of enrollment of patients with cerebral amyloid angiopathy, an age-associated disease in which a protein called amyloid beta builds up on the walls of the arteries in the brain increasing the risk for stroke and dementia.

AbCheck s.r.o. announced that it has entered into a collaboration with a biotech company developing antibodies targeting peripheral neural response, funded by a top-tier European Venture Capital firm.

LEX Diagnostics announces the appointment of Scott O’Brien to the LEX Board.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) market approval for the BD Onclarity™ HPV Assay to be used with the ThinPrep® Pap Test.

Sensorion, a pioneering clinical-stage biotechnology company, specialising in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, invites you to attend its R&D Day on Thursday 6 April 2023, at 8 am EDT.

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for its respiratory syncytial virus (RSV) vaccine candidate PF-06928316 or RSVpreF for the prevention of medically attended lower respiratory tract illness (MA-LRTI) and severe MA-LRTI caused by RSV in infants from birth up to six months of age by active immunization of pregnant individuals.